Acetate has been proposed as an astrocyte-specific energy substrate for metabolic studies in the brain. The determination of the relative contribution of the intracellular and extracellular compartments to the acetate signal using diffusion-weighted magnetic resonance spectroscopy can provide an insight into the cellular environment and distribution volume of acetate in the brain. In the present study, localized 1 H nuclear magnetic resonance (NMR) spectroscopy employing a diffusion-weighted stimulated echo acquisition mode (STEAM) sequence at an ultra-high magnetic field (14.1 T) was used to investigate the diffusivity characteristics of acetate and N-acetylaspartate (NAA) in the rat brain in vivo during prolonged acetate infusion.
However, the distribution volume of acetate in the rat brain during prolonged acetate infusion is not known. To study the transport and utilization of acetate in the rat brain, Deelchand et al. 8 assumed the same distribution volume for acetate as for glucose (V d = 0.77 mL/g), whereas Patel et al. 7 considered a smaller distribution volume for acetate, equal to 0.32 mL/g, based on the hypothesis that acetate is mainly localized in glial cells (whereas glucose is found in glial and neuronal cells). The assumed value for V d impacts on the reported parameters for acetate transport kinetics. To our knowledge, the acetate distribution and relative partitioning into the intracellular and extracellular compartments of the brain, measured using the non-invasive NMR modality, has not been reported.
Most in vivo NMR spectroscopy modalities do not distinguish between intracellular and extracellular contributions and provide information about the whole-tissue properties, such as metabolite concentrations in intact tissue. 1, [9] [10] [11] [12] However, this information is important for accurate metabolic modeling. By measuring the translational displacement of metabolites in tissue and providing information about the cellular environment, diffusion-weighted magnetic resonance spectroscopy (DW-MRS) could help in this regard (for reviews, see Cao & Wu, 13 Nicolay et al. 14 and Ronen & Valette, 15 and references therein). DW-MRS can differentiate between the signal originating from intracellular and extracellular compartments based on their different diffusion properties. 16 Therefore, DW-MRS is likely to yield insights into the distribution volume of acetate in the rat brain.
H DW-MRS remains a very challenging technique from the perspective of the acquisition of robust and reproducible DW-MRS data and
their subsequent processing and quantification. DW-MRS contrast is based on the random translational displacement of a metabolite; therefore, any type of bulk motion could result in amplitude or phase fluctuation of the NMR signal. The influence of eddy currents on the spectral line shape is not particular to DW-MRS, but the application of strong diffusion-encoding gradient pulses significantly increases their effect. In diffusion measurements, it is important to note that all the gradient operations in the pulse sequence should be taken into account when estimating the diffusion weighting strength (b-value), including the slice selection and crusher gradients as well as the main diffusion-encoding gradients.
A few studies have used DW-MRS to assess the diffusion properties of metabolites in the rat brain in vivo. [17] [18] [19] [20] [21] [22] Most studies have focused on the diffusion properties of particularly abundant metabolites, such as N-acetylaspartate (NAA), which are predominantly located in the intracellular compartment. Pfeuffer et al. 23 performed a DW-MRS study to test the hypothesis predicting a uniform distribution of infused glucose in the extracellular and intracellular spaces of the rat brain, and characterized the diffusion properties of 14 metabolites.
The application of a similar strategy, 1 H DW-MRS of brain acetate under prolonged acetate infusion, could also provide information on the intrinsic diffusion properties of acetate in the brain and yield an insight into the cellular compartments that constrain its diffusional displacement.
The overlapping of metabolite resonances in in vivo spectra complicates the quantification of each individual metabolite. The challenge in the study of acetate diffusion behavior is the overlap of the acetate 1 H-MRS resonance (1.90 ppm) with a γ-aminobutyric acid (GABA) resonance at 1.89 ppm, which hinders an accurate estimation of the concentration and diffusivity of acetate. Therefore, the purpose of this study was to address the diffusion characteristics of acetate in the rat brain in vivo using DW-MRS techniques at steady-state concentration, whilst minimizing the contribution of the overlapping GABA resonance.
2 | METHODS
| Animal preparation
All experimental procedures involving animals were approved by the local veterinary authorities. Seven male Sprague-Dawley rats (200-235 g delivered from Charles River Laboratories, L'Arbresle Cedex, France) were prepared without fasting. Animals were intubated and ventilated with 2% isoflurane during surgery. Both femoral veins were catheterized for the administration of acetate and α-chloralose. Two arteries were cannulated for the continuous monitoring of physiology (blood pressure and heart rate) and periodic blood sampling for blood gas, plasma lactate and glucose concentration measurements. Following surgery, anesthesia was switched to intravenous α-chloralose administration (bolus of 80 mg/kg and continuous infusion rate of 26.7 mg/kg/h). Animals were placed in a home-built holder and the head position was fixed using ear rods and a bite-bar. The body temperature was maintained between 37.0 and 38°C with a temperature-regulated circulating water bath.
| Acetate infusion protocol
The sodium acetate infusion protocol was optimized on the bench and in the magnet to reach a steady-state concentration of acetate in the rat brain in less than 30 min, whilst keeping the animal within physiological limits throughout the study. After the adjustment of MRS parameters and shimming, a bolus of 1 g/kg of sodium acetate (1.6 M) was administered with an infusion rate decaying in a two-step process over 10 min (Figure 1 ). This bolus was followed by a continuous infusion of acetate at a rate of 1.4 g/kg/h.
In order to avoid metabolic alkalosis in the blood of animals during the study, 24 ,25 the acetate solution was infused at an acidic pH (pH 5.0) as used previously in rats.
8,26
2.3 | In vivo and in vitro NMR spectroscopy at 14.1 T Spectra were acquired on a 14.1-T MRI system interfaced to a 26-cm horizontal bore magnet (Magnex Scientific, Oxford, UK; Varian, Palo Alto, CA, USA), equipped with an actively shielded gradient (inner diameter, 12 cm) reaching 400 mT/m in 120 μs. A home-built quadrature transceiver with two physically decoupled 12-mm-diameter loops was used.
After initial setting, fast spin echo images [TR = 4 s and effective echo time (TE) = 40 ms; four echoes] were acquired to select a volume of interest (VOI) of 450 μL in the rat brain ( Figure 2 ). Magnetic field homogeneity was adjusted using FAST(EST)MAP. 27 Localized 1 H NMR spectra were acquired using the stimulated echo acquisition mode (STEAM) sequence. 23 Acquisition parameters were optimized for acetate detection and are described further below.
Water suppression was achieved with seven consecutive chemical shift-selective (CHESS) adiabatic radiofrequency (RF) pulses followed by crusher gradients. Outer volume suppression was performed using eight adiabatic pulses followed by crusher gradients, which were repeated three times during the CHESS preparation to minimize the unwanted signal. One spectrum was acquired with the same VOI, but without application of water suppression, in order to provide a signal reference for quantification of the metabolites. 
| Diffusion weighting acquisition parameters
The diffusion-weighted STEAM (DW-STEAM) sequence described by Pfeuffer et al. 23 and Kunz et al. 28 was used to investigate the metabolite diffusivity characteristics in vivo in the brain of seven adult rats. Diffusion gradients are placed during the time delay τ in the STEAM sequence:
The signal attenuation of the 1 H diffusion is determined by the following acquisition parameters: diffusion gradient amplitude G diff , duration of the applied diffusion gradients δ and separation of the diffusion gradients Δ, which define the diffusion time t D = Δ -δ/3
and give rise to a b-
All of the gradient pulses, including both diffusion and STEAM gradients, were considered in the b-value calculation using a home-built Matlab script (The MathWorks, Natick, MA, USA). Diffusion gradients were applied in three orthogonal directions simultaneously in order to reach higher diffusion weighting. To vary the diffusion weighting of the signal in this study, only the diffusion gradient amplitude was changed, whereas the other parameters were kept constant.
To test the performance of the DW-STEAM sequence with the acquisition parameters optimized for the in vivo detection of acetate (as 
| Processing and quantification of the data
To prepare the acquired spectra from individual animals for analysis, the phase variations were corrected scan by scan by maximizing the NAA resonance height; then, the phased spectra acquired at the same b-value were corrected for B 0 drift and averaged together.
In vivo

1
H NMR summed spectra were processed using LCModel (Stephen Provencher Inc., Oakville, ON, Canada) and the unsuppressed water signal acquired from the same voxel was used as a reference for eddy current correction and determination of the apparent metabolite concentrations. No baseline correction, zero filling or apodization functions were applied to the data prior to the quantification. The Cramér-Rao lower bounds (CRLBs) calculated by LCModel were used as a measure of the reliability of the metabolite estimates.
The basis sets required by LCModel for spectral quantification were generated by simulations of all the metabolites detected in the spectra of the rat brain during continuous intravenous acetate infusion. The metabolite signals were simulated using the NMRSCOPE B plugin in JMRUI (http:// www.jmrui.eu) with the appropriate chemical shift and J-coupling patterns as described by Govindaraju et al. 29, 30 and STEAM sequence parameters used in this study. To validate the J-modulation characteristics of the simulated spectra, a series of in vitro experiments, using a phantom containing 50 mM glutamine (Sigma Aldrich, Saint-Quentin-Fallavier, France) and 25 mM creatine (Cr) (Sigma Aldrich, Buchs SG, Switzerland), was performed, varyingTE from 2.8 to 100 ms with steps of 10 ms or less (TM = 20 ms and TR = 10 s). The macromolecule (MM) signals were measured experimentally in vivo in the rat brain with aTR of 4 s and the optimized values of TE and TM found for the accurate quantification of acetate (as described in Section 3.1). The measurement was performed by preceding the DW-STEAM sequence with an inversion recovery (IR) as described by Kunz et al. 28 IR with a non-selective, full-passage, hyperbolic secant RF pulse and inversion time (TI) of 1 s provided the best suppression of the metabolite signal with the acquisition parameters used in this study (data not shown). To attenuate the residual metabolite signal after IR, diffusion gradients with a strength of 
To determine the confidence intervals of the adjusted parameters, Monte Carlo simulations were performed with 500 artificial datasets generated based on the bootstrapping method. 34 Curve fitting based on the Levenberg-Marquardt algorithm and further numerical procedures were performed in Matlab using in-house scripts. 
where k intra was determined from the contribution ratio of fast and slow components of a known intracellular metabolite, like NAA, simplified as:
The main goal of the present study was to assess the acetate diffusion properties in vivo in brain tissue and to compare them with those of a reference intracellular metabolite, NAA. To this end, the acetate infusion protocol and DW-STEAM sequence parameters were optimized to ensure a reliable assessment of the diffusion behavior at steady-state acetate concentration in the rat brain.
| Apparent concentration of acetate in brain tissue
To minimize spectral signal loss as a result of macroscopic motion, respiration cycle triggering was applied during acquisition and each FID signal was stored separately. The high quality and signal-to-noise ratio (SNR) of the acquired 1 H spectra enabled us to apply phase correction to individual spectra before signal averaging. The higher sensitivity provided using a surface coil at high magnetic field (14.1 T) with efficient B 0 shimming using the FAST(EST)
MAP method yielded a linewidth of 20-25 Hz, 27 with a typical NAA singlet resonance SNR of 14 averaging 16 scans acquired with a voxel size of 240 μL.
To reduce the signal overlap between the acetate singlet and the GABA resonance at 1.89 ppm, a long TE of 50 ms and TM of 49 ms in the STEAM sequence were used ( Figure 3 ). This resulted in well-resolved acetate resonance (1.90 ppm) in spatially localized 1 H NMR spectra with and without diffusion weighting ( Figure 4 and Supplementary material). The NAA singlet SNR of the spectra used in this study was higher than 20 for all b-values (0-18 ms/μm 2 ) , which was sufficient for a precise quantification of the detected metabolites (CRLB ≤20).
To ensure detectable acetate concentrations, an optimized infusion protocol was used to raise brain acetate concentrations to measurable levels, whilst maintaining the animal within physiological limits throughout the study. The acetate concentration time course in the rat brain reached steady state in less than 30 min (Figure 1 ). Brain acetate concentration during continuous intravenous acetate infusion reached 3.5 mM (±20%) at steady state (Figure 1 ), estimated after correction for T 1 and T 2 relaxation of the signal. (Table 1) . To determine the diffusivity of acetate and NAA for 2-3 h during continuous intravenous acetate infusion in rat, diffusion-attenuated spectra were acquired using the DW-STEAM sequence with optimized parameters (TE = 50 ms and TM = 49 ms). With increasing diffusion weighting up to b = 5 ms/μm 2 ( Figure 4 and Supplementary material), the acetate intensity dropped by 65% and NAA by 35% of their respective intensities without diffusion weighting. Fitting a mono-exponential decay to the normalized attenuated signal relative to the b-value range ( Figure 5 ) enabled the determination of an ADC of 0.09 μm 2 /ms for NAA and approximately three times higher ADC for acetate, i.e. 0.24 μm 2 /ms, with a coefficient of variation lower than 5% (Table 1) . When extending the measurement to higher b-values, the normalized diffusion-attenuated signal for NAA and acetate was clearly non-linear, indicating a multi-exponential decay ( Figure 5 ). Increasing the diffusion weighting to higher b-values up to 18 ms/μm 2 resulted in signal attenuation of 83% for acetate and 63% for NAA compared with their initial amplitude. At maximum b-value, the NAA signal was still above the noise level of a single FID spectrum and the mean CRLBs estimated by LCModel for NAA and acetate quantification in summed spectra from a single animal were 2% and 10%, respectively. In addition, other prominent brain metabolites, such as glutamate, taurine, Cr and phosphocreatine (PCr) (not addressed in this study), were well quantified with CRLBs of less than 10%.
To characterize the non-mono-exponential decay of acetate and NAA, normalized attenuated metabolite signals were fitted using Equation 2
over the entire b-value range (0-18 ms/μm 2 ) in Figure 5 . Bi-exponential fitting provided ADCs for the fast and slow decaying components of the acetate and NAA signals ( Table 2 
| Precise quantification of acetate in the rat brain in vivo
Acetate is present in brain tissue at concentrations too low to be consistently detectable by 1 H NMR in vivo, even at 14.1 T, for the measurement of acetate transport across the blood-brain barrier and dynamic 13 C MRS of labeled acetate. 1, 8 The infusion protocol was optimized to provide a stable acetate concentration in vivo for extended time periods, which reached a readily detectable steady-state level of 3-4 mM (Figure 1 ).
The challenge to establish the reliable measurement of acetate diffusivity was to minimize the GABA resonance at 1.89 ppm which could interfere with the quantification of the acetate resonance, particularly at high diffusion weighting, as GABA is larger and less mobile than acetate.
GABA has six NMR-observable protons in three methylene groups, forming an A 2 M 2 X 2 spin system. The triplet resonances for GABA-H4 and GABA-H2 appear at 3.01 and 2.28 ppm, respectively, whereas the GABA-H3 quintet is centered at 1.89 ppm and thus overlaps with acetate. The acetate methyl resonance is a singlet peak and does not undergo J-coupling evolution, whereas the GABA resonance could be suppressed using its unique J-coupling properties at a specific TE and TM. Therefore, application of the optimal parameters in the DW-STEAM sequence to minimize the GABA peak at 1.89 ppm (TE = 50 ms and TM = 49 ms) allowed the quantification of acetate with minimal contamination from the GABA signal.
However, the application of a long TE during 1 H MRS acquisition leads to substantial signal losses from T 2 relaxation and, accordingly, requires more averaging to achieve sufficient SNR for quantification.
With a TE of 50 ms, CRLBs obtained from the LCModel quantification were lower than 10% for acetate and NAA in reference spectra, as well as in all diffusion-weighted spectra. The high precision of the estimated metabolite concentrations is ascribed to the high spectral resolution and SNR of the 1 H spectra acquired at 14.1 T and preprocessing to correct the phase and frequency drift of individual spectra before averaging and quantification of the metabolite signal.
The acquisition parameters (TE and TR) used in this study result in T 1 and T 2 relaxation effects on quantification of the measured signals, and this was taken into account and corrected using previously measured T 1 and T 2 relaxation times of the metabolites. 35 
| Diffusion characteristics of acetate and NAA
To interpret the diffusivity of acetate without applying the assumptions used for diffusion data modeling (for reviews, see Cao & Wu, 13 Nicolay et al. 14 and Ronen & Valette 15 ), we compared it with the diffusion of NAA, as NAA is known to be an intracellular metabolite mostly confined to neurons, 37 and therefore could be used for comparison with the diffusion properties of other metabolites, where the cellular localization may be less established. NAA is particularly suitable as a neuronal diffusion marker as it appears prominently in 1 H spectra of the rat brain, with its main singlet peak not subject to J modulation.
When considering a range of b-values of 0-5 ms/μm 2 , a mono-exponential decrease was observed, as judged from the linear decay for acetate and NAA in vivo signals in a semi-logarithmic plot ( Figure 5) . Furthermore, the application of respiration cycle triggering during 1 H spectral acquisition and single-FID phase correction generally avoided signal loss and the related overestimation of the metabolite ADC. 38 The consistency of the estimated ADC of NAA using b-values in the range 0-5 ms/μm 2 with previous studies performed at longer diffusion times 23, 33 implied that the FIGURE 6 Monte Carlo probability distribution of the estimated parameters in the bi-exponential model including the apparent diffusivity of the fast component (a), apparent diffusivity of the slow component (B) and relative contribution of the slow component (C) in the total signal for acetate (ace) and N-acetylaspartate (NAA). Artificial datasets (n = 500) in the Monte Carlo method were generated based on the bootstrapping method, i.e. every artificial data point corresponds to the average of seven points generated by sampling from measured dataset with replacement diffusion time chosen in this study (73 ms) was long enough to place the diffusion signal decay of metabolites in the diffusion time independence regime. 21 However, the ADC of NAA has been reported with slightly higher values in some studies, 22, 31 which could be explained by the shorter diffusion time used in these studies (10-20 ms) . A shorter diffusion time implies a smaller mean displacement of metabolites, which limits the interaction with the environment and increases the ADC. 18, 39 In addition, the lower metabolite ADC values reported here could be ascribed to the higher magnetic field used (14.1 T) and the resulting higher sensitivity and spectral resolution. (Tables 1 and 2 ).
D
App slow was determined for acetate with higher precision than for NAA (error of 10% for acetate and 40% for NAA). In our study, the rationale was to choose a sufficiently large b-value range for the study of the hindered diffusion of acetate. Fortunately, the fast diffusion component of acetate decayed rapidly and its contribution at b-values higher than 5 ms/μm 2 was less than 11% and reached a negligible level of 0.03% at 18 ms/μm 2 . Therefore, the acquisition of spectra with a b-value range of 0-18 ms/μm 2 was sufficient to determine both fast and slow diffusion components of acetate inside the brain for bi-exponential modeling. However, the b-value range of 0-18 ms/μm 2 might not be sufficiently high 
| Evidence of acetate localization in glial cells
Acetate has been proposed as a potential glial marker because of its almost exclusive uptake in astrocytes. 1, 7, 40 The estimated D App slow of acetate was slightly higher than that of NAA in Table 2 . However, at the diffusion time used in this study (73 ms), D The extracellular fraction of the acetate signal in the brain was estimated to be 43 ± 12% under the experimental conditions of the present study, i.e. continuous intravenous acetate infusion in the rat. The contribution of the acetate signal from cerebrospinal fluid and blood was assumed to be negligible because of the rapid signal loss at low b-values (free diffusion of acetate, 1.27 ± 0.01 μm 2 /ms). The estimated extracellular fraction of the acetate signal, 43%, is greater than two-fold the reported value for the extracellular fraction of glucose (17%). 23 Therefore, the difference in extracellular fraction of acetate and glucose implies a distribution of acetate distinctly different from the uniform brain glucose distribution. In other words, the intracellular and extracellular signals have approximately equal contributions to the total detected acetate signal.
After passing the blood-brain barrier, acetate will enter the intracellular or extracellular space, and may be either uniformly or unequally distributed between these compartments. Based on the results of this study, 43% of the acetate signal is assigned to the extracellular space, a region occupying approximately 20% of the volume of the whole brain. 44 Assuming identical acetate concentrations in the extracellular compartment and in the intracellular compartment in which acetate is localized, it follows that the intracellular fraction of acetate (57%) is in a cellular compartment occupying approximately 27% of the brain, suggesting that acetate may not have access to the whole intracellular space, but rather to a subpopulation of cells in the brain. With this assumption, the acetate physical distribution volume (V d ), i.e. the volume to which acetate has access, including the extracellular and/or intracellular space in the brain, is estimated to be 47%.
Alternatively, with its metabolic conversion, acetate may have a lower steady-state concentration in the intracellular space compared with the extracellular space. In this case, acetate will be distributed in a larger intracellular volume than that estimated above assuming equal concentrations (27%) and, consequently, acetate in both astrocytes and neurons would contribute to the intracellular signal. It is challenging to differentiate the concentration of acetate in different intracellular compartments because of the variable expression of monocarboxylate transporter (MCT) isoforms in astrocytes and neurons. 44 Nonetheless, this simplified assumption, of an equal acetate concentration in neurons and astrocytes, would result in an extracellular acetate concentration three times the intracellular level.
Although our data cannot exclude this possibility, we believe that the results are best explained by acetate having access to an intracellular volume less than the whole intracellular space, which is consistent with acetate being a marker for glial metabolism as suggested in previous studies. 1, 7, 40 The lower estimated value of V d for acetate in the rat brain is comparable with the acetate V d value (32 ± 12%) reported by Patel et al. 7 in a study using 13 C-acetate. There, a smaller V d for acetate than for glucose was found to achieve better fitting of To acquire data in this study, the sequence parameters (e.g. TE and b-value) were optimized for precise quantification and evaluation of the diffusivity of acetate in the brain. Therefore, these parameters may not be optimal for the assessment of the diffusion behavior of other metabolites in the brain, such as NAA. D Figure 6 ) or with a previous study by Pfeuffer et al., 23 where a much broader b-value range of 0-50 ms/μm 2 was used. The acquisition of spectra with sufficient SNR at a b-value of 50 ms/μm 2 requires more temporal averaging and results in a substantial increase in acquisition time.
The exchange of metabolites across the cell membrane could attenuate the intracellular diffusion signal, as has been reported for water diffusion inside the cell. 45 The transport of acetate across the cell membrane was assumed to have a minor impact on the intracellular attenuated signal at the given diffusion time used in this study.
| CONCLUSIONS
We conclude that the presence of acetate resonance in Finally, we propose that acetate probably occupies a different physical distribution space than water and some other metabolites, such as glucose. The revised volume of distribution value of acetate may have a significant effect on the results and interpretations of acetate metabolism in the normal brain, as well as in clinical and preclinical studies of diseases such as diabetes.
